MXPA06009549A - Metodo para tratamiento o prevencion de osteoporosis en individuos con alto recambio oseo. - Google Patents

Metodo para tratamiento o prevencion de osteoporosis en individuos con alto recambio oseo.

Info

Publication number
MXPA06009549A
MXPA06009549A MXPA06009549A MXPA06009549A MXPA06009549A MX PA06009549 A MXPA06009549 A MX PA06009549A MX PA06009549 A MXPA06009549 A MX PA06009549A MX PA06009549 A MXPA06009549 A MX PA06009549A MX PA06009549 A MXPA06009549 A MX PA06009549A
Authority
MX
Mexico
Prior art keywords
bone
measured
ospemifene
marker
bone resorption
Prior art date
Application number
MXPA06009549A
Other languages
English (en)
Spanish (es)
Inventor
Lauri Kangas
Risto Lammintausta
Taru Blom
Original Assignee
Hormos Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd
Publication of MXPA06009549A publication Critical patent/MXPA06009549A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MXPA06009549A 2004-02-23 2005-01-19 Metodo para tratamiento o prevencion de osteoporosis en individuos con alto recambio oseo. MXPA06009549A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/783,092 US20050187302A1 (en) 2004-02-23 2004-02-23 Method for treatment or prevention of osteoporosis in individuals with high bone turnover
PCT/FI2005/000034 WO2005079776A1 (en) 2004-02-23 2005-01-19 Method for treatment or prevention of osteoporosis in individuals with high bone turnover

Publications (1)

Publication Number Publication Date
MXPA06009549A true MXPA06009549A (es) 2007-04-10

Family

ID=34861145

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06009549A MXPA06009549A (es) 2004-02-23 2005-01-19 Metodo para tratamiento o prevencion de osteoporosis en individuos con alto recambio oseo.

Country Status (11)

Country Link
US (1) US20050187302A1 (enExample)
EP (1) EP1718287A1 (enExample)
JP (1) JP2007523209A (enExample)
CN (1) CN1972680A (enExample)
AU (1) AU2005215173A1 (enExample)
BR (1) BRPI0507912A (enExample)
CA (1) CA2557116A1 (enExample)
MX (1) MXPA06009549A (enExample)
NO (1) NO20064007L (enExample)
RU (1) RU2006133903A (enExample)
WO (1) WO2005079776A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) * 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
CA2641315A1 (en) * 2006-02-06 2007-08-16 Tethys Bioscience, Inc. Osteoporosis associated markers and methods of use thereof
US7504530B2 (en) * 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
JP5363344B2 (ja) * 2007-02-14 2013-12-11 ホルモス メディカル リミテッド 治療に有用なトリフェニルブテン誘導体の調製方法
JP5010034B2 (ja) * 2007-12-28 2012-08-29 エフ．ホフマン−ラ ロシュ アーゲー 生理学的状態の評価
CN102690347B (zh) * 2012-05-18 2014-06-25 北京北方生物技术研究所 分离i型前胶原氨基末端肽的方法
WO2014060639A1 (en) 2012-10-19 2014-04-24 Fermion Oy A process for the preparation of ospemifene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9418067D0 (en) * 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

Also Published As

Publication number Publication date
NO20064007L (no) 2006-09-21
AU2005215173A1 (en) 2005-09-01
EP1718287A1 (en) 2006-11-08
CN1972680A (zh) 2007-05-30
RU2006133903A (ru) 2008-03-27
BRPI0507912A (pt) 2007-07-10
AU2005215173A8 (en) 2009-09-24
JP2007523209A (ja) 2007-08-16
US20050187302A1 (en) 2005-08-25
WO2005079776A1 (en) 2005-09-01
CA2557116A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
JP3197129B2 (ja) ベンゾチオフェン類を含有する医薬組成物
Loose et al. Estrogens and progestins
CA2811456C (en) Pharmaceutical combination of resveratrol and progestin to treat and/or prevent myoma and/or endometriosis
US20010056099A1 (en) Method of reducing morbidity and the risk of mortality
US20030065008A1 (en) Selective estrogen receptor modulators in combination with estrogens
JP2005524630A (ja) エストロゲン受容体を介する軟骨破壊の抑制
AU2001258449B2 (en) Method for the treatment of climacteric disorders in women during or after the menopause
PL208972B1 (pl) Zastosowanie selektywnego modulatora receptora estrogenu
US20150352059A1 (en) Method for the treatment or prevention of lower urinary tract symptoms
CA2492287C (en) Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
Gennari et al. Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis
Kamboj et al. Centchroman: A safe reversible postcoital contraceptive with curative and prophylactic activity in many disorders
MXPA06009549A (es) Metodo para tratamiento o prevencion de osteoporosis en individuos con alto recambio oseo.
JP3621095B2 (ja) １７α−ジヒドロエキレニンのコレステロールを低下させるための使用
Gennari et al. Ospemifene use in postmenopausal women
UA79797C2 (en) Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
Gennari et al. Lasofoxifene: Evidence of its therapeutic value in osteoporosis
KR20070019700A (ko) 높은 골 전환을 가진 개인에서 골다공증의 치료 또는예방을 위한 방법
Howell Tamoxifen versus the newer SERMs: what is the evidence?
KR101756405B1 (ko) 스코폴린을 유효성분으로 함유하는 여성 폐경 후 골다공증 예방 또는 개선용 조성물
Santhanam et al. Antioestrogens and breast cancer
Balaburski et al. Practical Progress in the Chemoprevention of Breast Cancer with Selective Estrogen Receptor Modulators
AU2006201900A1 (en) Selective estrogen receptor modulators in combination with estrogens